355 results on '"Gumina, Richard J."'
Search Results
2. Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants
3. Abstract 18474: Impact of the Endothelial Nucleotidase on Vascular Function
4. Floppy mitral valve/mitral valve prolapse: A complex entity with multiple genotypes and phenotypes
5. Characteristics of JN.1-derived SARS-CoV-2 subvariants SLip, FLiRT, and KP.2 in neutralization escape, infectivity and membrane fusion
6. Distinct patterns of SARS-CoV-2 BA.2.87.1 and JN.1 variants in immune evasion, antigenicity, and cell-cell fusion
7. 342 Impact of the Endothelial Nucleotidase on Thrombosis
8. E-Cigarettes and Cardiopulmonary Health: Review for Clinicians
9. Impaired neutralizing antibody response to COVID-19 mRNA vaccines in cancer patients
10. Altered ADAMTS5 Expression and Versican Proteolysis: A Possible Molecular Mechanism in Barlow's Disease
11. Trauma-Induced Nanohydroxyapatite Deposition in Skeletal Muscle is Sufficient to Drive Heterotopic Ossification
12. Immune Evasion and Membrane Fusion of SARS-CoV-2 XBB Subvariants EG.5.1 and XBB.2.3
13. The role of CD38 in ischemia reperfusion injury in cardiopulmonary bypass and thoracic transplantation: a narrative review
14. Continued evasion of neutralizing antibody response by Omicron XBB.1.16
15. Complete deletion of Cd39 is atheroprotective in apolipoprotein E-deficient mice
16. Impact of cardiac-specific expression of CD39 on myocardial infarct size in mice
17. Kir6.2 Is Required for Adaptation to Stress
18. Neuregulin-1β induces proliferation, survival and paracrine signaling in normal human cardiac ventricular fibroblasts
19. Extracellular nucleotide regulation and signaling in cardiac fibrosis
20. Neutralization Escape of Omicron XBB, BR.2, and BA.2.3.20 Subvariants
21. Enhanced Evasion of Neutralizing Antibody Response by Omicron XBB.1.5, CH.1.1 and CA.3.1 Variants
22. UNIQUE USE OF AN IMPLANTABLE PULMONARY ARTERY PRESSURE SENSOR TO DETERMINE OPTIMAL TIMING OF DELAYED REPAIR FOR A POST-MYOCARDIAL INFARCTION VENTRICULAR SEPTAL DEFECT
23. Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2
24. Ectonucleoside triphosphate diphosphohydrolase-1 (CD39) impacts TGF-β1 responses: insights into cardiac fibrosis and function following myocardial infarction
25. Evasion of neutralizing antibody responses by the SARS-CoV-2 BA.2.75 variant
26. Distinct Neutralizing Antibody Escape of SARS-CoV-2 Omicron Subvariants BQ.1, BQ.1.1, BA.4.6, BF.7 and BA.2.75.2
27. Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants
28. Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2
29. Ectonucleotide Triphosphate Diphosphohydrolase-1 (CD39) Mediates Resistance to Occlusive Arterial Thrombus Formation after Vascular Injury in Mice
30. Changes in Plasma Profiles of Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of MMPs in Stress-Induced Cardiomyopathy
31. Dual Use of E-Cigarettes and Cannabis Among Young People in America: A New Public Health Hurdle?
32. Durability of the Neutralizing Antibody Response to mRNA Booster Vaccination Against SARS-CoV-2 BA.2.12.1 and BA.4/5 Variants
33. Estrogen Receptor-β Agonists Modulate T-Lymphocyte Activation and Ameliorate Left Ventricular Remodeling During Chronic Heart Failure
34. Transgenic over expression of ectonucleotide triphosphate diphosphohydrolase-1 protects against murine myocardial ischemic injury
35. Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants
36. Neutralization of the SARS-CoV-2 Deltacron and BA.3 Variants
37. Differential Evasion of Delta and Omicron Immunity and Enhanced Fusogenicity of SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants
38. Severe acute respiratory syndrome coronavirus 2 vaccination induces short-term polyclonal antibody response against seasonal endemic coronaviruses
39. Kcnj11 Ablation Is Associated With Increased Nitro-Oxidative Stress During Ischemia-Reperfusion Injury: Implications for Human Ischemic Cardiomyopathy
40. Role of adenosine A2B receptor signaling in contribution of cardiac mesenchymal stem-like cells to myocardial scar formation
41. Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection
42. Genotype-Guided Use of P2Y12 Inhibitors: A Review of Current State of the Art
43. Suppression of de novo antibody responses against SARS-CoV2 and the Omicron variant after mRNA vaccination and booster in patients with B cell malignancies undergoing active treatment, but maintenance of pre-existing antibody levels against endemic viruses
44. Erratum for Zeng et al., “Neutralization of SARS-CoV-2 Variants of Concern Harboring Q677H”
45. Neutralization and Stability of SARS-CoV-2 Omicron Variant
46. Loss of Neutralizing Antibody Response to mRNA Vaccination against SARS-CoV-2 Variants: Differing Kinetics and Strong Boosting by Breakthrough Infection
47. Guidelines for in vivo mouse models of myocardial infarction
48. Neutralization of SARS-CoV-2 Variants of Concern Harboring Q677H
49. Impaired Neutralizing Antibody Response to COVID-19 mRNA Vaccines in Cancer Patients
50. Effect on ex vivo platelet aggregation and in vivo cyclic flow with Na+/H+ exchange inhibition: Gumina, NHE-1 inhibition and platelet aggregation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.